amiodarone has been researched along with Pancytopenia in 1 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Pancytopenia: Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amiodarone therapy is associated with several adverse effects, including hematologic ones such as pancytopenia, hemolytic anemia, and aplastic anemia." | 8.84 | Amiodarone-associated bone marrow granulomas: a report of 2 cases and review of the literature. ( Aish, L; Mohamed, T; Oo, TH; Sanjay, R; Schneider, D; Sycheva, T, 2007) |
| "Amiodarone therapy is associated with several adverse effects, including hematologic ones such as pancytopenia, hemolytic anemia, and aplastic anemia." | 4.84 | Amiodarone-associated bone marrow granulomas: a report of 2 cases and review of the literature. ( Aish, L; Mohamed, T; Oo, TH; Sanjay, R; Schneider, D; Sycheva, T, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mohamed, T | 1 |
| Sanjay, R | 1 |
| Sycheva, T | 1 |
| Aish, L | 1 |
| Schneider, D | 1 |
| Oo, TH | 1 |
1 review available for amiodarone and Pancytopenia
| Article | Year |
|---|---|
Amiodarone-associated bone marrow granulomas: a report of 2 cases and review of the literature.
Topics: Aged, 80 and over; Amiodarone; Bone Marrow Diseases; Diagnosis, Differential; Enzyme Inhibitors; Gra | 2007 |